Showing BioInteractions for Tetrahydrocannabivarin (DB11755)

BioInteractor utilizes data on drug-target, -enzyme and -transporter associations to provide insight on drug-drug interactions. It allows you to identify, for instance, which drugs act similarly on the same target. Such drugs may have additive pharmacodynamic effects if given concomitantly. Conversely, two drugs may antagonize the beneficial effects of each other by having opposite actions on a specific drug target. BioInteractor uses ranked drug-enzyme association information to predict enzyme-mediated drug interactions that may be clinically relevant.
Interacting GroupInteracting Drugs
Tetrahydrocannabivarin is a Cannabinoid receptor 1 antagonist
1Cannabinoid receptor 1 agonistsDronabinol
2Cannabinoid receptor 1 partial agonistsNabilone
3Cannabinoid receptor 1 antagonistsCannabidiol, Propacetamol, Rimonabant
4Cannabinoid receptor 1 modulatorsCannabidiol
5Cannabinoid receptor 1 negative modulatorsMedical Cannabis
Interacting GroupInteracting Drugs
Tetrahydrocannabivarin is a Cannabinoid receptor 2 partial agonist
1Cannabinoid receptor 2 partial agonistsNabilone
2Cannabinoid receptor 2 agonistsDronabinol
3Cannabinoid receptor 2 inverse agonistsLasofoxifene
4Cannabinoid receptor 2 antagonistsCannabidiol
Interacting GroupInteracting Drugs
Tetrahydrocannabivarin is a G-protein coupled receptor 55 partial agonist
1G-protein coupled receptor 55 antagonistsCannabidiol
Interacting GroupInteracting Drugs
Tetrahydrocannabivarin is a 5-hydroxytryptamine receptor 1A agonist
15-hydroxytryptamine receptor 1A partial agonistsAripiprazole, Aripiprazole lauroxil, Brexpiprazole, Buspirone, Cariprazine, Perospirone, Quetiapine, Trazodone, Yohimbine
25-hydroxytryptamine receptor 1A agonists5-methoxy-N,N-dimethyltryptamine, Apomorphine, Brexpiprazole, Bromocriptine, Cabergoline, Cannabidiol, Cariprazine, Cinitapride, Eletriptan, Ergotamine, Flibanserin, Lisuride, Lofexidine, Methysergide, Naluzotan, Naratriptan, Pergolide, Pramipexole, Rotigotine, SEP-363856, Sumatriptan, Vilazodone, Vortioxetine, Ziprasidone, Zolmitriptan
35-hydroxytryptamine receptor 1A antagonistsAcepromazine, Alprenolol, Alverine, Amoxapine, Asenapine, Chlorpromazine, Clozapine, Dosulepin, Doxepin, Iloperidone, Lurasidone, Molindone, Nefazodone, Nortriptyline, Paliperidone, Penbutolol, Pindolol, Pipotiazine, Pirlindole, Pizotifen, Quetiapine, Risperidone, Thioproperazine, Trazodone, Trimipramine
45-hydroxytryptamine receptor 1A inhibitorsAmitriptyline, Escitalopram, Tianeptine
55-hydroxytryptamine receptor 1A inducersAmitriptyline
65-hydroxytryptamine receptor 1A bindersDesipramine, Dopamine, Loxapine
75-hydroxytryptamine receptor 1A activatorsImipramine
85-hydroxytryptamine receptor 1A blockersMianserin
Interacting GroupInteracting Drugs
Tetrahydrocannabivarin is a Transient receptor potential cation channel subfamily V member 2 agonist
1Transient receptor potential cation channel subfamily V member 2 activatorsCannabidiol
2Transient receptor potential cation channel subfamily V member 2 agonistsCannabidivarin
Interacting GroupInteracting Drugs
Tetrahydrocannabivarin is a Transient receptor potential cation channel subfamily M member 8 antagonist
1Transient receptor potential cation channel subfamily M member 8 inducersLevomenthol
2Transient receptor potential cation channel subfamily M member 8 activators(S)-camphor, Camphor
Interacting GroupInteracting Drugs
Tetrahydrocannabivarin is a Transient receptor potential cation channel subfamily A member 1 agonist
1Transient receptor potential cation channel subfamily A member 1 inducersLevomenthol
2Transient receptor potential cation channel subfamily A member 1 agonistsCannabidiol, Cannabidivarin
3Transient receptor potential cation channel subfamily A member 1 inhibitors(S)-camphor, Butamben, Camphor